References
- Leonard S, Adler LE, Benhannou K, et al, Smoking and mental illness. Pharmacol Biochem Behav.. 2001; 70: 561–570. [PUBMED], [INFOTRIEVE], [CSA]
- Breslau N, Kilbey MM, Andreski P.. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry. 1991; 48: 1069–1074. [PUBMED], [INFOTRIEVE]
- Hall SM, Munoz RF, Reus VI, Sees KL.. Nicotine, negative affect, and depression. J Consult Clin Psychol. 1993; 61: 761–767. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Glassman AH, Helzer JE, Covey LS, et al, Smoking, smoking cessation, and major depression. JAMA. 1990; 264: 1546–1549. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Glassman AH.. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry. 1993; 150: 546–553. [PUBMED], [INFOTRIEVE]
- Tompkins SS.. Psychological model for smoking behavior. Am J Public Health. 1966; 56(S2)17–20
- Waal-Manning HJ, De Hamel FA.. Smoking habit and psychometric scores: a community study. N Z Med J. 1978; 88: 188–191. [PUBMED], [INFOTRIEVE]
- Hughes JR, Hatsukami DK, Mitchell JE, et al, Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986; 143: 993–997. [PUBMED], [INFOTRIEVE]
- Covey LS, Tam D.. Depressive mood, the single-parent home, and adolescent cigarette smoking. Am J Public Health. 1990; 80: 1330–1333. [PUBMED], [INFOTRIEVE], [CSA]
- Pomerleau O, Adkins D, Pertschuk M.. Predictors of outcome and recidivism in smoking cessation treatment. Addict Behav. 1978; 3: 65–70. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rausch JL, Nichinson B, Lamke C, et al, Influence of negative affect on smoking cessation treatment outcome: a pilot study. Br J Addict. 1990; 85: 929–933. [PUBMED], [INFOTRIEVE], [CSA]
- Anda RF, Williamson DF, Escobedo LG, et al, Depression and the dynamics of smoking. JAMA. 1990; 264: 1541–1545. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Perez-Stable EJ, Martin G, Martin BV, et al, Depressive symptoms and cigarette smoking among Latinos in San Francisco. Am J Public Health. 1990; 80: 1500–1502. [PUBMED], [INFOTRIEVE], [CSA]
- Glassman AH, Stetner F, Walsh Raizman PS, et al, Heavy smokers, smoking cessation, and major depression. JAMA. 1988; 259: 2863–2866. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Burgess ES, Brown RA, Kahler CW, et al, Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse?. J Consult Clin Psychol. 2002; 70: 356–361. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shiffman S.. Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol. 1982; 50: 71–86. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hall SM, Munoz RF, Reus VI.. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994; 62: 141–146. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ahluwalia JS, Harris KJ, Catley D, et al, Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA. 2002; 288: 468–474. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hall SM, Reus VI, Munoz RF, et al, Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998; 55: 683–690. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hughes JR, Stead LF, Lancaster T.. Antidepressants for smoking cessation. Cochrane Database Systems Review. 2002; 1, CD000031. [CSA]
- Hurt RD, Sachs DP, Glover ED, et al, A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med.. 1997; 337: 1195–1202. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Prochazka AV, Weaver MJ, Keller RT, et al, A randomized trial of notriptyline for smoking cessation. Arch Intern Med.. 1998; 158: 2035–2039. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Murphy JK, Edwards NB, Downs AD, et al, Effects of doxepin on withdrawal symptoms in moking cessation. Am J Psychiatry. 1990; 147: 1353–1357. [PUBMED], [INFOTRIEVE]
- Niaura R, Goldstein MG, Depue J, et al, Fluoxetine, symptoms of depression, and smoking cessation. Ann Behav Med. 1995; 17: S061
- Bakish D, Ravidran A, Hooper C, et al, Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder. Psychopharmacol Bull. 1994; 30: 53–59. [PUBMED], [INFOTRIEVE], [CSA]
- Hellerstein DJ, Yanowitch P, Rosenthal J, et al, Long-term treatment of double depression: a preliminary study with serotonergic antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 1994; 18: 139–147. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Steiner M, Steinberg S, Stewart D, et al, Fluoxetine in the treatment of premenstrual dysphoria: Canadian fluoxetine/premenstrual dysphoria collaborative study group. N Engl J Med.. 1995; 332: 1529–1534. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dalack GW, Glassman AH, Rivelli S, et al, Mood, major depression, and fluoxetine response in cigarette smokers. Am J Psychiatry. 1995; 152: 398–403. [PUBMED], [INFOTRIEVE]
- Niaura R, Spring B, Borelli B, et al, Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychology. 2002; 70: 887–896. [CSA], [CROSSREF]
- Levine LR, Enas GG, Thomson WL, et al, Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study. Int J Obes. 1989; 13: 635–645. [PUBMED], [INFOTRIEVE]
- Pomerleau CS, Zucker AN, Stewart AJ.. Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers. Nicotine Tob Res. 2001; 3: 51–60. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- First MB, Spitzer RL, Gibbon M, Williams JBW.. Structured Clinical Interview of DSM-IV AxisI Disorders—Patient Edition. Version 2. 1995
- Beck AT, Ward CH, Mendelson M, et al, An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 561–571. [PUBMED], [INFOTRIEVE]
- Hughes JR, Hatsukami DK.. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986; 43: 289–294. [PUBMED], [INFOTRIEVE]
- Tiffany ST, Drobes DJ.. The development and initial validation of a questionnaire on smoking urges. Br J Addict. 1991; 86: 1467–1476. [PUBMED], [INFOTRIEVE], [CSA]
- Speilberger CD, Gorsuch RL, Lushene R, et al, Manual for the State Trait Anxiety Inventory. Palo Alto, Calif, Consulting Psychologists Press. 1983
- DiClemente CC, Prochaska JO, Gibertini M.. Self-efficacy and the stages of self-change of smoking. Cognitive Therapy and Research. 1985; 9: 181–200. [CROSSREF]
- Fagerstrom KO.. Measuring degree of physical dependence on tobacco smoking with reference to individualization of treatment. Addict Behav. 1978; 3: 235–241. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Blondal T, Gudmundsson LJ, Tomasson K, et al, The effects of fluoxetine combined with nicotine inhalers in smoking cessation—a randomized trial. Addiction. 1999; 94: 1007–1015. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hitsman B, Pingitore R, Spring B, et al, Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol. 1999; 67: 547–554. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hayford KE, Pattern CA, Rummans TA, et al, Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry. 1999; 174: 173–178. [PUBMED], [INFOTRIEVE]
- Hughes JR.. Tobacco withdrawal in self-quitters. J Consult Clin Psychol. 1992; 60: 689–697. [PUBMED], [INFOTRIEVE], [CROSSREF]